Back to the Top 100
Distalmotion logo

Rank 83MedTech & Devices

Distalmotion

Develops Dexter, a hybrid surgical robot that combines laparoscopic and robotic surgery.

Visit website
Signal Score
82.8
Total raised
$150M
Stage
Growth
Founded
2012
Headquarters
Lausanne, Switzerland
Region
Europe

Their signal

By offering a hybrid model that allows surgeons to easily transition between manual laparoscopy and robotic steps, it provides a highly cost-effective alternative to rigid systems.

Signal Score 82.8editorial estimate, see how it is built
Capital (25% weight)86

Total raised, quality of investors and recency of the last round.

Growth (25% weight)80

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)84

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)85

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)78

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in MedTech & Devices

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.